Elanco Animal Health Inc ELAN

Rank #1819 · NYSE · $11.5B market cap

Audited by Ernst & Young LLP, no going-concern flag in the latest filing.

Score

41.5

P/E

-9.4

P/B

1.58

ROE

-16.9%

Op. Margin

–%

Debt Ratio

89%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆

Average

P/E -9.4x, P/B 1.58x. Ranks in the top 56% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -16.9%. Ranks in the top 81% of the universe.

Safety ★★★☆☆

Good

Debt ratio 89%. Ranks in the top 36% of the universe.

Growth ★★☆☆☆

Weak

Revenue growth of 0.1% year over year. Ranks in the top 63% of the universe.

Safety is the relative strength · Profitability is the relative weakness (relative to this universe).

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2018	$2.9B	–	$-0.0B	$7.4B	–	16
2019	$2.9B	–	$-0.3B	$7.0B	–	54
2020	$3.1B	–	$0.1B	$7.8B	–	44
2021	$3.1B	–	$0.1B	$5.2B	–	177
2022	$4.8B	–	$-0.6B	$5.5B	–	162
2023	$4.8B	–	$-0.5B	$8.5B	–	97
2024	$4.4B	–	$-0.1B	$7.5B	–	108
2025	$4.4B	–	$-1.2B	$7.3B	–	89